<SEC-DOCUMENT>0001354488-15-001832.txt : 20150420
<SEC-HEADER>0001354488-15-001832.hdr.sgml : 20150420
<ACCEPTANCE-DATETIME>20150420163021
ACCESSION NUMBER:		0001354488-15-001832
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150420
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150420
DATE AS OF CHANGE:		20150420

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WOUND MANAGEMENT TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11808
		FILM NUMBER:		15780961

	BUSINESS ADDRESS:	
		STREET 1:		777 MAIN STREET
		STREET 2:		SUITE 3100
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-820-7080

	MAIL ADDRESS:	
		STREET 1:		777 MAIN STREET
		STREET 2:		SUITE 3100
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TWISTEE TREAT CORP
		DATE OF NAME CHANGE:	19910220
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>wndm_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
    <title>wndm_8k.htm</title>
    <!--Licensed to: Issuer Direct Corp-->
    <!--Document Created using EDGARizerAgent 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Washington, D.C.&#160;&#160;20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Report</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pursuant to Section 13 or 15(d) of the</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Exchange Act of 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date of Report (Date of earliest event reported): April 20, 2015</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="FIS_UNIDENTIFIED_TABLE"><!--EFPlaceholder--></a>Wound Management Technologies, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Texas</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">000-11808</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">59-2219994</font></div>
</td>
</tr><tr>
<td valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(State or other jurisdiction of incorporation)</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Commission File Number)</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">16633 Dallas Parkway, Suite 250</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Addison, Texas</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">75001</font></div>
</td>
</tr><tr>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Address of principal executive offices)</font></div>
</td>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(zip code)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Registrant&#8217;s telephone number, including area code: (972) 218-0935</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr><tr>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="2%"><font style="DISPLAY: inline;" face="Wingdings">o</font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr><tr>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="2%"><font style="DISPLAY: inline;" face="Wingdings">o</font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>
</tr><tr>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="2%"><font style="DISPLAY: inline;" face="Wingdings">o</font></td>
<td width="1%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="97%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr></table>

&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 7.01</font></div>
</td>
<td align="left" valign="bottom" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Regulation FD Disclosure</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information provided pursuant to this Item 7.01 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing or other document filed by Wound Management Technologies, Inc. pursuant to the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document. The information provided pursuant to this Item 7.01 shall instead be deemed &#8220;furnished.&#8221;</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 20, 2015, Wound Management Technologies, Inc. (the "Company") announced that it will conduct an earnings conference call on Wednesday, April 22, 2015 at 3:00 p.m. CST during which the Company will discuss first quarter 2015 results and provide an update on recent activities. The press release announcing the conference call information is attached as Exhibit 99.1.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01</font></div>
</td>
<td align="left" valign="bottom" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Statements and Exhibits</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) Exhibits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><a href="wndm_ex991.htm">Exhibit 99.1</a> <font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;&#160;&#160;</font>Wound Management Technologies, Inc. press release announcing conference call on first quarter 2015 results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="s0468741b5f044689aab8b20273c495db"><!--EFPlaceholder--></a>SIGNATURES</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font></font>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Wound Management Technologies, Inc.</font></font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> </font>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: April 20, 2015</font></font></div>
</div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Darren Stine</font></font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> </font>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Darren Stine</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> </font>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chief Financial Officer</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<hr style="COLOR: black" noshade size="2">
 &#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>wndm_ex991.htm
<DESCRIPTION>WOUND MANAGEMENT TECHNOLOGIES, INC. PRESS RELEASE ANNOUNCING CONFERENCE CALL ON FIRST QUARTER 2015 RESULTS.
<TEXT>
<html>
<head>
    <title>wndm_ex991.htm</title>
    <!--Licensed to: Issuer Direct Corp.-->
    <!--Document Created using EDGARizerAgent 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-WEIGHT: bold">Exhibit 99.1<br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold"><img src="logo.jpg" alt=""></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Wound Management Technologies, Inc. Schedules First Quarter 2015 Earnings call for Wednesday, April 22, 2015</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Addison, TEXAS, April 20, 2015</font> &#8211; Wound Management Technologies, Inc. (OTC QB: WNDM), <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX&#174;</font>, today announced&#160;it</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;will conduct a quarterly earnings call on Wednesday, April 22, 2015 at 3:00 p.m. CST.&#160;&#160;Robert Lutz, Jr., CEO, will discuss first quarter 2015 results and provide and update on recent activities.&#160;&#160;A question and answer session will follow the presentation. Shareholders, analysts and other interested parties may join the call by dialing 1-712-775-7031 passcode 604070847# shortly before 3:00 p.m. CST.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About Wound Management Technologies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market.&#160;&#160;Wound Management&#8217;s primary focus is the distribution of its Wound Care Innovations subsidiary&#8217;s unique, patented collagen product line, CellerateRX&#174; which is FDA-cleared for all wound types except 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> degree burns. The wound care product line is reimbursable under Medicare Part B and the surgical products are reimbursable as part of procedural billing.&#160;&#160;Wound Management has other advanced biotech products in development including a patented resorbable bone hemostat line that is in late stages of development.&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">For more information visit </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">www.wmgtech.com</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To download Wound Management Technologies&#8217; investor relations app, which offers access to SEC documents, press releases, audio casts and more, please visit <font style="DISPLAY: inline; TEXT-DECORATION: underline">http://bit.ly/1zhNwnO</font> to download on your iPhone and iPad or <font style="DISPLAY: inline; TEXT-DECORATION: underline">http://bit.ly/149PgWc</font> for your Android mobile device.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Information about Forward-Looking Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the Company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investor Contacts:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Robert Lutz Jr. / Darren Stine</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">972.218.0935</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">rlutz@wmgtech.com</font> / <font style="DISPLAY: inline; TEXT-DECORATION: underline">dstine@wmgtech.com</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!9`5P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_*\7_;%_
MX*"_"?\`80\*+J7Q'\56FE3W"%[+2X!]HU+4,''[J!?F(SQO;"`]6%>!?\%I
MO^"O=A_P3>^&D&A>'%M=4^*OBFV:32[:4;XM(M\E/MLR_P`7S`K&G\;*Q.0A
M!^0_^"?'_!!/Q1^V+KJ?&S]K76/$5_=>(W74(/"\]T\=_?(WS*]_*"'A0C&V
MVCVE5P"4QL'I8?!0]G[?$NT>G=^AQU<1+G]E15Y?@AGQ)_X.1OC'^U'XRG\+
M?LS?!F^O)R=BW5Q8RZSJ('9S##B&#_MHTB^]9]G^Q/\`\%-_VPB+KQ=\2KKX
M=V-[\YAN/$XTS8I[&WTQ"./1L'UK]C/A%\%/"'P!\%6WASP3X:T3PKH=FH6*
MRTNS2VB&!C)"@;F]6.2>YKB/CU^W]\%/V8'DC\>_%'P5X:NHCAK.YU.,W@/_
M`%P0F7_QVMHXZ*?+A:2^:YF9O#-KFKU'^2/RS?\`X-=_B_\`$G][XZ_:,LKR
M=^9,:;>:ESW^::X0G\J5_P#@TEUG3L3:=\?+>.Y3E6;PJZ8_%;O(KZY\8_\`
M!R5^R?X4NGBM_&7B#7=AQOTWPW>NC?1I(T!K!L/^#GW]EJ\GVO>_$"U']^7P
MS*5'_?+$_I71]9S6VD7_`.`K_(R]C@>K7W_\$^8I?^"!W[9'P.B\_P"''[2,
M$YMCNBMXM=U71F?';"F1/S.*SKK]J3_@I?\`\$\5-SXX\)7WQ(\,67SS3RV$
M.O6ZQCJ6GLBMRG'>3IW%?H!\,/\`@O'^RA\5+B&"V^+NCZ1<S':L6N6ESI>#
M[O/&J?\`CU?4O@?X@Z#\3=`CU7PWK>D>(-+F_P!7>:;>1W<$GT>,E3^=8U,=
M7CIB:2?K&QI##4GK1FUZ.Y^='[%/_!S9\(OCWJ%OH?Q+TZY^%6O2-Y7VN>;[
M7H[R=,-,%#P'/_/1-J]WK])=%UNS\2:1;:AIUW;7]A>Q+-;W-M*LL,\;#*NC
MJ2&4CD$'!KY:_;T_X(T?!']OK2[NZUOP[#X8\:R(?(\4Z%$EM?J_.#,`-ERN
M3R)03@<,O6OS'^%'[0'QW_X-S?VE++X>_$DW'C3X*>(9VELI8"S6MS#N&^XL
M2Y_<7,>09+9CM;/<,LHGZM0Q2OA?=E_*_P!&5[:K1=JVL>Z_4_>>BL'X8?$S
M0OC-\/-&\5^&-2M]8\/^(+2.^L+R`Y2>)QD'U![$'!!!!`((K>KQVFG9G?>^
MJ"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@#\+_\`@FSX%@_X*S?\%O?B1\6_%X&L^%/A
MY=/J^FVDXWP.RS&WTJ(J>-L<432D=#)$I(Y-?LU^T9^T)X5_94^"?B+X@^-=
M0_LSPUX8M#=W<P7?(_(5(XUZM([E45>[,!7Y&?\`!HN/^)U\>?\`KEHG\[ZO
MI?\`X.@96C_X);W05F`?Q9I"L`?O#S'.#^(!_`5[N.I^TQ\<,_A5E\K(\S#3
MY,,ZJW=V?'.N_M>_MA_\%X/'^JZ%\'[>^^&'PEMIC;W$MM>-8QI&>GVV_4>9
M+*5()@M^`",JP^8^\?LZ_P#!J5\-_#$,=]\3_'?B3Q=JTGSW$&D(FG6K.3R&
M=Q)+)_O90GT%?6__``1*TFUTC_@EG\'1:6T%L)](>>411A/,D:XE+.<=6)ZG
MJ:^J:RQ&8U*4G1P_N13MIN[=V71PD)Q52K[S?<_`;]M7XM_L?_L`?M+:G\-/
M"O[,-I\1#X1D$.O:KJ_BB_7][A6>.)29!A-V&=@!N!`7`!/K?[,7[3__``33
M_::%OIGB+X4Z-\,=5N`$"ZU'*EDY_P!F\@E*@?[4OEUF_L6:?!JO_!T#\6[:
MZ@AN;:>/Q"DL4J!TD4F#(93P1[&ON+]KS_@@M^SE^UG:W=S_`,(?#X!\2S@L
MFM>%`NGR;\<&2``P2C/)W1Y/]X=:[J]>C3Y:=5R3:3YE)]?(YJ5*I+FG!1M=
MJS2.+\<?\&ZG[)WQO\.+J'AG2]8\/6^I1>;;:AX=\0R7,,BD?*Z>>9XV7Z<&
MODKXJ?\`!O?\?/V%-:G\;_LO_%75+^XL\S'38)SI.IRJ.=FS<;:[Z<K)MST"
MD\5R'B[X)_M:?\&\?BB7Q+X4U@_$;X)&XWWI2*23350M_P`OEIN+6<AR/W\3
M%2<`O_`?7_VC/^#HJ+QG\&O#VE?!'P1J[_%/Q4HMYX-0M_MD>C3L=HCMXX\F
M\E8\I\JK@J64G*`@L:FO8S]I!]]5\[ZH)?5[?O(\DEV_0Z[_`()T_P#!Q3:7
MD^L^`OVJ4M_AWXU\+12,^NRV4EK;ZB8N)()[8*7@NQR0BC;)R%"L`I^<?^"R
M7_!=[X6_MV?!C4/A/X,^'&I^(;:YNHKC3_$VLO\`8YK&YC;Y9K.V4-*S$%E^
M<IN5V!4YKN/V6O\`@WA^)O[9_C:7XJ_M7^,]:TZ_\0,EU/HMK.DNM78V@*+F
M?!CM@%"J(HU8J`!E,8'ZB_LQ_P#!.OX)_L=V$,?P]^''AK0KN$#.I&V%SJ4I
M`QN:ZEW3$G_>Q[5C5JX"A5]I!<TNR?NI^O\`2+A#%5:?))V7GN?GQ_P:E_M+
M:KXK^$WQ$^%6IS336G@ZZ@U?25D/-M'=&1;B$#LHEC5\?WII#WKZ#_9&_P""
MU9_:3_X*#:]^S_JWPX;PGJ^@3ZI9OJ)UO[4MS/8R%2JQ>0A`9$D;.XXVCKG-
M?'?_``:WG/[7/[0G_7/_`-R$]8W[1%BO['__``=`>%M<#?9-.\::UI]TI/RJ
M5U*W^PS$^QG:8UIB,-2J8JM%K7ENO6R)I5IPH4Y)Z7L_2Y^H'_!3S_@H1I__
M``37_9R@\>WN@GQ-+>:Q!I%KIHOA9F=Y$DD8^9L?&U(G/W3VZ5ZM^S=\:;3]
MH[]G[P5X^L8?LMKXQT2TU=+?S/,^S&:)9&B+8&2A8J3@<KT%?E[_`,'-=OKO
MQZU[PE\.O#?ERCP'X5U7XDZ]$6.5M(Y(K:.3'^S^_P"O]ZO8?^"%?[65O%_P
M1AGUO4+A)&^#T>L6UX6;D1VZM?1@^PBF51_NUY\\%'ZG&M'XF]?1['7'$OZQ
M*F]K'TQ^Q'^W$?VT?%/Q9AL_#)T?0_AKXLN/"=KJ1OO/_MN6!F\R4)Y:^6`O
ME$#<V?,Z\5[]7P!_P3*^(_AO_@GS_P`$9M'^*/Q'OFM(=<^U>+]4ECCW3ZA/
M>W!^SI$F?GDDB%N!R!SDD*"1S2_\%[_$O@3PAX/^)'Q$_9^\0>$?@AX^OOL>
MC^*8=<BO;I0=Q666T$:LJLJ.ZC<"RHQ3?QF*F"G.I)4(Z)VWW:[7W[Z%0Q,8
MP3J/5JY^DE%?*?\`P43_`."KGA;_`()]?"CP-XSGT&^\;:%X\E9+"XTJ\C12
MAA6:.0%@0R.K`@CMS5K]M#_@IWI7[%G['G@GXP:QX/U?5M.\82V$+:=:74:S
MZ>UU9R7*[F8;6V^7L.,9)S7-'"59*+2^+1&SKTU=-[;GU%17P_\`M2?\%M_#
MO[*_[+?P>^*.J>`]=U&P^,&GM?VEE;7T*R:=^YAE59&88;*RCD#C::\/^*W_
M``=$>#_A_P#'+3=+T_X;:WK7P\N'6*;Q.M[Y+W!!"S26D+1;9HXWW*"9%W[?
MX016U/+<345XQ[]NAG+&48Z2D?JA7YP_\')G[1_Q`_9D_9M^'VM_#[Q?K_A"
M_O?$SV-U/I=TT!N(VM96"N1U`*9`/?GM7TW^W3_P4=\#?L+_`++$'Q1U4OKU
MGK/D1^'[&SD"2:W+-&9(PC,,*GE@NSD'"CH6*J?R$_X+%_\`!36]_;Q_8C\`
M6GBCX:>(?A=XC;Q%#X@TJ"^\R:R\0:6]M=1BZM9VCCW!7,88;<8D1@Q!..G*
ML)4E6A4<?=O;^D8XVO!4W!/6Q^W'['VN:AXG_9*^%VI:M>W&I:KJ/A'2;J]N
MYW+RW4SV<322.QY+,Q))[DUSG_!0;]L*#]@W]D[Q+\4+C13XB7P^]I&NG"[^
MRFZ:>ZB@QYFQ]N/,+?=.=N.];O[%:&+]CCX3*PPR^#-'!'H?L,-?*'_!R+)?
M:G_P3F3PYI=O+>ZGXO\`%NEZ3:6L0S)<R9EG5%'<DPUR4*<9XI0ELW^%S>I-
MQHN2WL?7W[+OQ]TW]J7]G;P9\0])C\BQ\7Z3!J2VYD\PVCNH\R$M@9:-PZ$X
M'*&O(O\`@J9_P4GTO_@F3\#=(\6WF@-XJO\`7-732K/2DOOL;2?NY)'E,GEO
MA4"*#\O61?6OE7_@UG_:;_X6+^R)XG^&EY<;]0^'>K?:;2-FY%C>[I``/:=+
M@GT\Q?6OE;_@Z!^->H_%O]I[3?#FG"2;PO\`"2VMK#49E;]W%JVIH]SY9[%C
M;6T1]MK]*[:&7IXYT)_"ORZ?H<]3%M8958[O\^I^[OA37T\5>%M-U2(;8]2M
M8KI!G.`Z!AS^-:%?+$/[=7A;]D[_`()D_"[XF>*(]4U*/5?#.B6NG:?IEN9[
MS5[^XLHVCMHEZ;F*ORQ``4]3@'YV^!'_``<2_P#"0?M8:1\,/BS\%_$OPBD\
M37<-KIMUJ5U(TT!G;;`;B"6")EC=B!YBDA<\C`)'%'`UIJ4H1NE?\#HEB:<6
ME)ZL_3"BOCS]O[_@L5X3_P"">_[17@WP#XG\,ZG>Q^+[2WO?[8CO(X;73HY+
MIX':4,"V(PA<D=0<5X%\.O\`@YH\)>+_`-KS3/`VI_#C6_#_`((\07T5EI?B
M6\O-EPZ3.$ANI;5HAMA<E22)"54Y^;&*(9?B)PYXQTW"6+I1ERR>I^H%%?+7
M_!0;_@IS9_L5:_H_A#P[X"\5_%;XG^(K)]2L/#6A6\C,EHK,AN9I$CD*IO5E
M`5&.5.=HP:X'_@EK_P`%KM$_X*(?$/7?`6L^#;[X>?$'0;=[MM-GN_M,5W''
M((Y@K-'&Z2QLR[HV7."2"=K`0L'6=+VRC[O]?,KZQ34_9WU/N.BOASXV_P#!
M834Y_P!KK7/@A\"_A;<?%_QMX2M)[O7I7UJ/2K&Q\@#S84=D<R2*[)&?N@2.
M%&<'$?\`P2[_`."O?BG_`(*5>.=3MK;X/1>%O#'AY&BUC6#XLANY;&Y*[H8V
MM##'+MDVR`/]W,;#J*IX&LH>T:TWW77;3?7H+ZS3<N1/7YGW/17YS_$;_@O5
M?ZOXD^(]Y\'O@SJ7Q1^'GP>`D\6>*?[=BT^%(][*7MHS&[2I\DC!@<E(V8J%
MP3[!\0O^"P7@3PM_P3KTW]H_1M'U;Q%X8O;B"TGTV*6."]L9GE,,D<F<KNCD
M&#@X8$$'!!H>!KJUX[Z=-WT?;Y@L52=[/8^N**_*GXP_\'1OA;P=H/A'4_#'
MPMUKQ'9ZK'')KDTNIBWAT>1RQ%HD@B=9;@1!9"/E"AP,DAMN_P#M;_\`!R_X
M&^"UQX<D^'O@G4?B1I.HVEI>:IJ;7W]GVNFM<0B9;/<(I0UTL9!=#@(?ER2&
MVZ_V7BFTN3?T(^NT-^8_3>BO"M"_X*(_#?4_V$K?]H:ZU"?3O`<ND_VG)YJ`
MW,3A_)-KM!PT_G@P@`X+XP<'-?)6B_\`!P3J6@V7@GQQX^^!NM>#?@E\1M2E
MT[0_%IUR*[N!Y;[&FFM%C#*G#'&[)6-RGF8YQIX*M._+';3Y]O-ERQ-.-KO<
M_2JBOCW_`(*%?\%A?"G_``3T^*'@;P[K?AK4-=MO'5J+NVU2UOHHK6V3SA&6
M<L#\H#!]P[&OGO3O^#G;P;+^U?8>$+WX=:SIOP\U>[CM;+Q7<WOES2PR2;([
M[[*T0_T9OO<2;MN3@D;*NGE^(J1YX1NA3Q=*,N63U/OS]J7]KKX??L9?#.;Q
M7\1/$=GH.F)N6WC=MUSJ$H&?)MXA\TCGT`P.I(&37<>#O$\'C;PCI>LVJ3QV
MVKV<5["DRA9$21`ZA@"0&PPR,GFOQE_X.L/BI?Z]J'P_\*S>#/$%C8^'[R>Y
MM?$D\8&G:H9X(2\,+=2\94;A]*_4S]AKXQ:K\;/V>-)U+5_`7B?X=3V*IIT6
MF:]&$N9HHX8MLX`_@;<0/]TU5;!\F&A6ZRO_`,`FGB.:M*GV/RV_X-%_^0U\
M>?\`KEHG\[ZOI;_@Z$_Y1<S_`/8VZ1_Z,>OFG_@T7_Y#7QY_ZY:)_.^KZ5_X
M.AY!%_P2VN68A57Q;I)))P`/,>O3Q'_(V7K'\D<=+_<7Z/\`,\T\-?\`!531
M?^"9_P#P1&^"T]J-/U;XC>(M`=-`TBX<E(U%Q+OO+@`AA`G89!=L*"`'9>)_
M8`_X.`_B=X9_:4TKP-^U'IMOH.C^-K6WO=)U>?2O[+DTQ+D;K::1>%:TE!QY
MA&4/+-@-CSC_`((G_P#!%KQ'^U)XA\-_&+XZVVI?\*_\/Q0_\(KX>U8N9-=2
M,[H7>-^8[%"=RQX'FDYQL)W_`*/_`/!77_@E%X>_X*8?!6&*W>TT'XD>%XW?
MPUK;)\@SRUG<;1EK>0@=,F-L.O\`$K%:6"IU71FK\S=Y=K[6].O](5-8F4%4
MCI:UEW/A']AOG_@Z-^*A[%/$!!]0?((-?L=\3OB5HOP<^'>M^*_$EZNF^'_#
MME+J.HW;(SK:V\2EY)"J@L0J@DX!/'2OP3_X(/?"+QQ\!O\`@MNWA/XD:5JN
MC>,-)\,:K'>6^H,7D=0L`21)#D2Q,H&R125*XP>U?LI_P4\_Y1S?'+_L1M7_
M`/222N?-()XFG"]U:*-L%)^QE+K=GK/A?Q3X>^,G@"UU72+[2?$OAGQ#:>9!
M<V\B75GJ%O(,<$95T8$@]1U!KP3]EG_@D=\"OV./CKXE^(G@?PA%9^(?$,A:
MW-P_GP>'XV`\R*P0C_1T=LEL$GG:"$`0?AO_`,$B_P#@JCX\_P""9&NZ7+K5
MKK6M?`CQ7?26^H6!1GCLYT\LS75B3\HGC$D;20@XD5ER`Q5J_:[_`(*!_P#!
M6_X=_L5?LAZ9\2]-U#3_`!C>>-[8-X)T^TN/EUYW0,LI8<K;QAE:1L9&0OWV
M`J,1@,1AZGL:;;4M-.OKZ%4L52JP]I/1Q/</C9^U/X"_9XUSPGI7BWQ)8Z7K
M'CK5[?0]`TXMON]4NII%C58XERQ4%@6<C:@ZD9&?0:_F%^"7Q,^*GQX_X*U_
M`'XA?%R;5;K7_'/B_1=6TZ6\C,,3:>VH>7%]EB/$=L&CD"`#!VELMG<?Z>JQ
MQ^!6&Y8WNVM33"XGVW,[62/Q-_X-;_\`D[C]H3_KG_[D)ZO_`/!TQX+NOAQ\
M>?@7\6--3;=P1SZ>TPX*2V=Q'<P9/N9Y<?[IJA_P:W_\G<?M"?\`7/\`]R$]
M?3O_``<Z_"+_`(6#_P`$WUUV.)GN/!/B2RU`LHR5BF$EJP^A:>(_\!%>K4J<
MF:J_6R^]'#"/-@7]_P")I?LK>'-)_P""@'[87[5OCJ22&]\*ZIX=L/A?H\Z_
M.!;26'GWZYZ?ZZ:,X'K7Y>_L)_&[6/@U^QC^U9\#W98_%'BFXTK1M*L&;#27
M<VH#3[R,#U,4@S_N5^N7_!OW\$O^%+?\$O/`KS1^7?\`C"2Z\277&"_GRE86
M]\V\4%?G?9_L;&3_`(.?9?#OV+_B41^*SXY;Y?W>S[-_:@..F//(3ZT8:I#V
ME:D]HI-?]N?YA6A+EIS6[O\`^3?Y'JO_``<ZN?@A^R#^S[\*]*D:/0;6:1/+
M3Y5<:=:06\.?HMP_%>P?\%K/`UCX<_X(+:)IT<,:Q>'++PU':*`,1%!##Q_P
M!V'XUJ_\')_[&?B+]IO]D'0_%'A/3KG6-7^&6HRW]S96T9DFEL)HPMPZ*.6*
M-'"Q`_@#GM7S9_P4-_X*`^&/VW/^"4GP9^%'PYNG\5?%+QM/I-A?^&["-I;V
MRDM("LP=`,KFX6/9GAD)8<`U&%O4IT''[,G?RZZ_(JO:$ZJEU2M^7YGB'[<W
MCF\\;_\`!`[]DZ:_+R3V^MZG8I(QR1#;2W,$:_01J@'LHK[/_P"#@:V6'_@B
M[\-DZB'5-!"D^VG7`KR__@L]^P?KW[/?_!&+X&>'[.U;46^%%Y'_`,)$]JI=
M+>2ZBD:>;(_Y9"Z;8&_Z:)ZUX-_P4+_X*;:E_P`%`_\`@F3\/?"^A>"/$.G6
M?P_O--A\7ZS<B/[%+J*6DT%O!;%26?S%$\Q!"E`@'/6NJE'VSI5*?PJ<K_-Z
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M\BO&/^"Q?[.FM^+_`/@E[^R3\7=`M+FZMO!/@_3=.U9XHRQM8Y[.T>"9QV19
M(G0D\;I4'>L/_@N%_P`%%]#_`."B7[*'PLE\`V6KWFE:)>Q7?BBZELI88=-U
M:>V<1:>K,H$LBI'=NQ3*A0AW'=6E"+E*A*&T7*_EK^I%1J,:BENU&Q^S_P"Q
M?,;C]COX3N>K^#='8X][*&OG_P#X*C7J:U^TE^R)X98Y^V_%&/6=G]X65K(W
MZ><*][_8AE\_]B[X0O@KN\%:,<'J/]!AKY2_;SU]_$O_``6M_8[\,*28]*AU
M[694`X&^T<(Q_&U(KP<.O]HD^RD_P9ZE5_NE\OS1\&_L[^.]._X(T_\`!>'Q
MSH&O70T3X<:VU[;RROQ##I]S&+ZR8#H2CK#%G_?%6/VYOAIJ?BK_`((AR?&/
MQ%`8_%'QE^+?_"=W8?YFMK6:&]M[2$'_`)YK%AD]I:]M_P"#D#]@34?CO^T7
M\"/%'ARW_P!.\;ZG#X`OI53(CE>4RVKM_P`!>Z))Z+$/2O;O^#@CX6Z=X$_X
M(XW?A_1[<0:7X0NM$M+"$#_50Q2I;HH^BL!7LQQ,)2H5%\4K)_+3\7^1Y[HR
MBJD7M&]OF==^Q=^TY\-/@?\`\$<?@G\0OBCJ.E6&@^&M#M([2>\@^T2+>0"2
MWC%O&`SM/A)`NP;@-QX`)'YM?\%K?VK[G]L[XU_`+QYI7PY\2^#?"-Q)/!X=
MUK6TCM[[Q.BW-NS2I`K,R0(60QLQ^?SV(KAOVID\1_$'_@@U^S3J=K%=S:#X
M,\2Z[I6L&-2R6\TMR[VK2>GR&503QEP,Y89Z[_@KE^V=X>_:ZT#]FSQCX,T#
MQ#:_#OP%&-*O-6N--:"UBU$K:236$>1\[P10*25^4[_E)P:UPN$4*_M4KMRF
MO);_`(LBM7<J7(]+*/SV_(]G_P"#BOPG:>/O^"G_`.SAH6H1K-8:U;V-A<QM
MT>.756C8'ZAC5G_@ZQ\'V.C^-O@!K5G;16VHLNI:?YD*!6,,+V;Q)QV1I9-H
M[;SZUC?\%O\`XJ:'\4?^"E?[*/BKPWJ$6JZ#J%GI&J6=]"I\N>W?5V9)!D`X
M(4GD5T'_``=;ZD(_'_[/D05F:`ZM<.%[+YE@/Z'\JSPMU/#)]I%5[.-9^:/T
M'_;+_P""@GPA_82U_1[GQ9'<ZK\1?%%I'9:3HNA::+W7]6A\QO+B0#!$9F9@
MH=E#.6VAB#C\S/V%_$VN>+O^#EW6]8\0>#YOA]JVM07][<>'Y;B.::R6321(
MGG-'\OFNA25U_A>0@\BI?^"D_P`38?V3/^#ASP'\4OB';:@?`*6NGWME<K;M
M<*EL+1K=WC4`[C%<EY"JY;H0,L,YWP!_:7T>'_@XY/Q*\4V.J>#/#GQ(MR?#
MDFL6CPR7UO<Z<EK8S[,%E6Y\M2N<8,@!P<UGA\*J="3BK\T&[^?9>A56MS5$
MF[6DO^'.L_X)5W]G^QU_P6__`&C=%^)>H6GAJ\U2UUB[L[S5)EMXKR%M0BO%
MD5W(!WV_[WZ*WI7G_P#P2%M_$?@?]EO]MWXRZ5!=6.@7'AJ^MM&N0K(L]TL5
MW-E/>%9(B3V\T>]=+_P4-_;X\(?#C_@LSXPM?VA/A;_PL/X>>$M"CT3P[I9L
MH7>S\Y+:Y-ZJR[5F+MYJY+#:KX!^4@_8W[''_!0G]G[_`(*A_!3QI\!_AYI%
M_P##U[SPO>V$6@WFEV]E$EI-&T+R6ZP.\9V&56*Y#<YP0"15>514O:N#M)0N
M^B2_KY"I*#GR*6L7*W?4^"?^"+WQ&\>:9_P3V^-'@SPA\"O%/Q+@\>W=]I5S
MK.FZC:6]O9M+IJ1+"Z2D,Q7S2YQQB0=\T[7?V8_B=^RA_P`&^?QA\,?$_P`-
M:AX8NW\>Z=J.FVMW)&Y,4C6:,R[&8`%HR/KFMK_@C;^W'I7_``1[^)_Q4^"G
M[0-OJG@U9=02_M[P6,US%%<QJ8G^6-6=XYHQ$T<BJ5(3KA@:^DO^"P_[5-A^
MV%_P1,\5>-M#T36=)\.ZQXDLK;19-3A\F?5[6*[CQ=K'U2.1EDV!N2JAN-V!
MI6G46*45'W92B^;77\;$4XP="[E[R35CROQO\*=$TG_@U%L7ALH5F,=MKAE"
M#>UU)KBHTA/][RV,>?[H`Z5/\//AKHC_`/!J/JKMIULTES;76L22%!O:[36R
MBRYQG<$C1,]=JXZ5?^)^KA?^#4#2MOWI=.LK4+C)+#Q`JG_T$TOP[UI%_P"#
M3_43MP4TV[M2IZ[CX@9/YM65Y<O_`'&+LN;_`+AGRG\:?'NI:)_P;>?!W189
M9$M-;^(E^LXR<211->2!/IYC!L>J^U>U?M">"_C1^VQ_P25^#'PH\(_LW>,X
MHO#5GH^J6'B%]4LGM]1C2QDC:9(]RLHF\_>,\@'GFJWP]_8[UK]L7_@VG\/6
MGA>PGU+Q1X#\3:AXBM+&%"T]XL=S<I/%&HY9O)F9PH&6,84#)%>P?\$RO^"\
MWPL^$O["'A;P/XWC\3#XD^!+,>'[30-/TB>ZN-?\HE+5+=E78'*>7&5D92&4
M]016]2<[.5&/-*,WWT\]#.$8W2J2LG%?\,?.O_!9CX9ZZ=._8?\`"OC>UFL_
M$!\(6>BZS:RN/-AG5K.*56()&021D$\@UZ]_P=B^!-(T/P+\#+ZRL+:SN+*7
M4M,A:",)LME2U9(AC^%2#M'0;CCK61_P<=Z[/J/[6O[,=[?64FFW?V);R\M"
MXD-DS7D!9"PP&*D,,CKMKI?^#MJ\#^"O@A9KN,CWFL2[1Z!+,9_\>J,-)N>&
M??G_`%*JI*-9?X2E_P`'36H/)^SC^SXCL6:>6]E8GDL1;6G.?^!5^P7A",1>
M$]+51A5M(@!Z#8*_)+_@Z,\#:GXH_9*^!_BFRM)9M'TB\FMKR9$++;M=6T#1
M%B.@/D.,],X'<5^DO[%W[67@?]L?X'6/BCP%K`UG3;3R].O&%O+";6[6WAED
M@(D52659DR5RN21G(./+Q,6\%2DMDY7^\[J+2Q$T^MOR/RO_`.#1?_D-?'G_
M`*Y:)_.^K]?OB[\#?"'Q\T/3],\:>'M,\3:;I>I0:O;6FH1>=`EU`28I2A^5
MBI)(#`C.#C@5^+G_``:T_&3PC\#K+X^:UXS\3^'_``II,<6B9N]7U"*SB./M
MQ(#2,,GV'J/6OI_]LC_@YX^"GP3L[K3OAA;WWQ8\1X*0S6X:QT:)\'EKB1=\
M@![1(P/]X=:WS'#5ZN.E[%/I^2ZF6$K4X89>T??\S]!OC)\:?"?[.WPTU/Q=
MXUUW3?#/AG183+=WU[)Y<42CH`.K,>BHH+,2``2<5\]_\$]O^"Q?P@_X*-ZW
MK6B^$[R^T3Q-I-Q-Y6BZTJ6][J-FK'9>0*&(=&7!90=\9.&`X)_,;X,_LC_M
M+_\`!PEXSTWXA_%GQ4GA?X/VUU(VGQ6N%LXPKE)(["S#$M*,%3<3DD8/+8V5
M[Q^W'_P;4V6C:;H_C#]F+6M2\*>-?"\4+1Z?=ZK(C7\T0`%S!=Y#07)QDCB)
MB>/*&<Y_4L+3_<UJGOOMLO)E?6:\_P!Y3C[OXOT/U.U;X5>&]>^(>D>+;S0]
M,N/$^@P36NGZJ]NOVNTAF`$L22?>"/@97."0#C(KRK_@I[_RCF^.7_8C:O\`
M^DDE?F;^S=_P<,_%?]C'Q4GPW_:R^'NOW5WIFV%M<MK,6FL(@X$DUNVV*Y4X
M_P!;$R[NN')S7UU^TW_P4W^!'[8__!.7XU0^`?B5X;U/5+CP+JQ&D7,_V'4U
M8V<GR_9IMDA/;Y5(]":Q>`KTJL7)75UJM5N:+%4JD'RNS[=3Y8_X(@?L4>$?
MV_/^"-'CKX?^+HMD5SXWN[C3=0C0-/H]XMA9".YBSW&<,N1O0LI/.:H?LG_\
M&QGC73OCWH<WQI\9Z!X@^&?@R5CI^DZ=>W4\FH1&5I?LX21$6VA>0[Y`A).6
M`Y;>/<?^#57_`)1X>)/^QWN__2*QK],JZ,9CZ]&O4ITWHW_5C+#X6G4I0G):
MV/Q._P""K&FV^C?\'$W[,]G9P0VMI:'PK#!!"@2.&-=4N0J*HX50```.`!7[
M8U^)G_!5/6+37_\`@Y$_9\M[&Y@O)].O/#%M=1P.':VE&HSRE'`^ZPC='P?X
M6!Z&OVSK',/X5'_":83^)4]3\3/^#7'/_#6O[0N,9\KC/_80GK[2_:/^-7[1
MWP&^+?P?\'7GB_X2:U_PMSQ!/HK3#P1=JFDK'%YP?!U$^=QQ@[.F:^+_`/@U
MM4M^UK^T(P&5\L#/;G4)\?RK[I_X*27`3]L[]CV,_P`?CN];.?2Q88_\>KJQ
MUOKTHM7T_*)AAM,,FN_ZGL&G?&-_V4/AS!+\>/B1X`BO-4U8V6DW=EISZ+;S
MJ44QVZ023S,\ORR$E6Q@C@8R>O\`A]\?/A_\5/!^I>+_``_XDT'4=#T=Y8+_
M`%=)56"T,2*\@DE;`4*K`MDX`/-?,7_!78ZC'\5/V59-'M=/O-63XK6OV2*^
MN'M[>23[-,0'D1'95R!DA&/'0UG?\%//%WB34?!'[._A3X@VNA:1IGQ`^+FD
MZ5XJLM-O9+W3;VS6226*TDEEBB+I*T<1<-&HRA'(&3Y\<.IJ+ZROVZ7Z?(ZW
M5<7)=OZW/I'P5^W'\)/B%JMY9:3X\T*XN+#39=9E5Y&A4V,7^MND:0*LD*9!
M,B$J`0<\BI_#'B3X1:'\/;CXNZ3_`,(5IWAZ\L6U*X\4P6L-NDUMR6E><*&*
M<'DGFI_VN[*$_LJ?$M_)CWQ>$-61&V#**;.3(![`X''L/2OSY@7XP_\`#@8A
M8_A;_P`(1_PJICG??G4_LWV0DG&/*\[_`,=W>U*C0C45T[:I;CJ590=GKHV?
MHCJG[0OPZO?^$.TR^\4>''/Q1MR_ARSN9TSXAA,(E)AC;_6*8W4GC'SJ.K`&
M]IS^!_A=K.C>"[*#P]H-WK:W-YIFCVMM';_:A`$\^6.)`!\GFQ[FQ_&OJ*^%
MOC7^QS;_`+:GPS_9[\/6FIR>'_&7A_X02>(/!^L0N8Y-'U6W;0C#+D?P'.QN
M"0&R/F45TO[*_P"V#>?M7_%7X7W^NZ8ND_%KX<:7XJ\.>,=`<!);34XTT_+J
M@.?)F,09",KRRACL)IO"KDYHOO?\;/TT$J[YK-=K?A<^E_C)^V+\'?@?K4ND
M>,?%WA[3+O341[J"1#/_`&8L@RC3[%86ZL,$&3:".>E=#XW^/?P[\&_#'3?%
MNM^)O#4'A+4I((M.U.2YCDL[MYN(5A<95R_\.W.:^</^"&=W:_$S_@FQH?B'
M5?*U;7_'.JZUJ7BR>YA!DU*_EU"X24S@CYCY2QIAOX%4=*^,8/#TGA7_`()G
M^)_"N&_X1CPE^TX=%\,HS$K'I\6IQ!5CS_#YC3].Y:M(X.#J.FV[II/_`(!+
MQ$E%3[JY^Q>LPZ=!X>NDU!;)-*2W<7*W`46ZPA3OWAOEV;<YSQC->+?"?]KK
M]GR?Q1IW@3PAXI\"V-YJTC2:7IMG"EE;ZH_&YK4[%BN">.8BV1BO+/\`@N'X
MLN-!_9+\,Z6\KP^'O%WC_0M#\2LK%%;2Y)R\Z.PQA'\I$;L58J>"12?\%V_`
MFEW_`/P3#\9ZEY4=EJ7@B73=6\/74"B.72[R.]@CC:`CE&*R-&-O9\"L:%",
ME!2;]]V]-O\`,TJ56N9Q^RKGT[\6OCAX/^`'AR#4?%VOZ9X>LKB46MK]HDP]
MU*1Q%#&,O*^`3M12<`G&!7.^#OVN/A5\1?`6N^--+\8>'KG1/"&]=9OY7\DZ
M-M7<RW`D"O"=ISAP.#7S=\&/$MW\1_\`@M%KUKXQ4-J_@;X3Z<^@6LP^6U:[
MEC;4+F)3PLC2%(6<<[5"YQQ6Q_P4=_:)\'>+OV:_VJ?AMI23KXO\(>`WU'7#
M]C\N)UNK1C`1+_RT;8H'L`!GC`:PJYHT];NS;Z).W^?WB]L[.7K^![UX]_;#
M^%/PYT/PIJ7B+QSX:TRT\:6XO_#SW5RJMJL/EK)YL"_>90DB$L!P'&>M2ZA^
MU9\,)?@U#XZN?%V@2>"[RY^R6^HO)N@O)Q(T8BB&,RR;U90B`L2IP#BOA'QQ
M=:]8_M-?\$Z)?#%CH^H:ZO@'6!;0:I>26=J^=!LPV^6.*5UPN2,1MDX'&<U]
M#_MT?LW?&+XS^'OA+\0/`\WA*S^*?PEU276_^$=N[F6?1-8::`PRP"=DC;>$
M+".1D3_6-RAPP;PU.+BI.U[]?-K]-Q*M-J32V_R7^>Q[[\.?&G@7]HWX6C4/
M#L^A^*?"6JM)`WEPK+;3,CE)(WC8?>5U*LK#(*X(R*Y']KBUTCX-_L7>/M2T
MOPEX3O;?P/X;U#7-+T>]TN.33!<6UO+/&#`H`QO7G;@\G!%9G_!/[]L:+]L[
MX/ZKJUQX5O?`_BCPIKMUX;\3Z#<L)#IFJ0;&G19``)%/F*=V`<DYZ9.M_P`%
M`I!#^P?\:F8A5'@36R2>W^@3U@HN%90?<TYE*GS+L<[^SG^U/X>UW]E3X'^*
MOB7J_A70_$_Q2T?2_L4$H2V6^O[J".06]LC$G[S@*H)QD>M>P^+/%OAS1/$6
M@Z5K-WIL6I^)+B2TTFVN-IEOI8X7GD2,'DE8HW<^@4FOSOU3]EK1?VUOV)/V
M.OA_JMU-8_VG\/'N-,U&WD9)=*U"'1K1[:Y3:028Y!DKGD;AQU'9_LH_M0:S
M\??B;\(_!?Q)2"P^-WP6\7ZAH?BRS+C=>AM!U%8-3B&!NAN$"MN``W$X`5DS
MTU,+%ISB]KW7;>WRTLS&%9JT7Y?I<^G/VB_CQ\%?`^J6^D_$K4_"$E[81_VB
MEEJ-HM_-I\?:Y:,(YA3@XD8*ORGGBN\TC2O"7Q,_L/QC9VF@:XSVB7&CZU'!
M%</]GE4.KP38)",K`@J<$&OEG_@BQKB?$KX)?$SQOJ6V?QAXM^(^M2>()I/F
MG22&18H+9B>0D5N(E2/HJMP!DY^Q[:VCL[=(88TBBB4(B(NU44<``#@`"N:O
M%4Y.FKW1O2DYKG[GYR?\$F_^$?\`VX/C=^TKXQ^*.B:#XM\<:7XVD\/P6NLV
M45Z=!T>#S%MK:&.56$4>_P`\-M`WLA+9.37EG[+W[-7ASPA_P<K^-_\`A66D
MV>E>$?!>@/>ZQ;Z;&([&PNKFQBB:%`ORH6EFW>6,8*R``!<#[%^,/_!(7X>?
M$?X^ZE\3O#?BCXF_";QGKW_(9OO`NO\`]E_VOG[QF4QNN6X)*A<L-QRWS5ZO
M^RA^QCX!_8O\'W^D^!]+GAEUFZ-]J^J7UR]YJ>M7)))FN;AR6D;+,0.%&YL`
M;CGNEC(+GE!OWHVMT6W](Y8X>3Y5);.]^_\`74[7QC\)_"WQ$N[:?Q!X:T#7
M9[/_`(]Y-0TZ&Z>#O\A=25Y]*V9-.MY;18&@A:!``L90%%`Z8'3BIZ*\J[V.
M^Q`=,MC:"W^SP>0.D?EC8._3I0-,MA:>1]G@\C_GGY8V>O3I4]%(".UM(K*+
M9#%'$F<[44*,_05@V_PB\)VGC!_$,7ACP]%K\A+-J::;"+QB>I,NW?\`K714
M4[M;!8KW6EVU](&GMX)F48!>,,1^=+>:;;ZAM\^WAGVYV^9&&QGKC-3T4@*6
MO^&].\5Z)/IFJ6%EJ6G72>7-:74"S03+UPR,"I'`X([4>'_#FG^$M'AT_2K"
MSTRPMAMAMK2!888AZ*B@`?@*NT47=K`?S'ZI_P`$[/!'@O\`X+!W_P`"?BMK
MNK>!/!M[KTUMH^JVD<67BG/F:>IDE!1%E1DC,F&VR$`]R/VI\`?\$$_V7_AY
M\&M=\'6_P\AU#_A(K%["\US4KAKO6E!Y$D-P_P#J'5@&!B5!D#((R*QO^"T/
M_!(;3O\`@I+\,H-9\/M::5\4_"]NT>E7<WR0ZK!DL;*=AT&XEHW_`(&9NSL1
M\<?L!?\`!>#QC^Q!KZ?!+]K30O$EK)X<9;&V\2S6SRZCI\8X1;V/EKB/&-MQ
M%N8K@D29WU]'4K5\71C.A)\T=X_JNYX\*=+#U'&JM'L_T./U[]B[]L;_`((7
M>/\`4]=^"]Y?_$_X5W,QN)X+2S-ZKQC./MNGJ=Z2!0`9K;J!]Y!\M>V_L^?\
M'77@360FG?%/X=^(_"VK0GR[F?19$OH%<=2T,IBEB_W<N1ZFOT]^#'QY\%_M
M%^"H/$?@3Q3H?BW1+D`I>:7>)<1@D9VMM.5;U5@".XKF/CK^P[\'OVFED/C[
MX9^"_%4\GWKJ^TJ)[K\)@!(/P:N.6.I5';%T[R[K1_,Z5AIPUH3T[/5'R?\`
M$/\`X*U?L(?MH>"?['^('B#P_K%B<[;7Q#X:O1+;,>ICE\@^6W^U&X/O7PO^
MT=^PY_P3I\9WW]H>#?VB[KP'E]YM!97.MVL8STC1HA,#[M*WTK]"?&/_``;F
M_LE^+;AI(OA[J&B%OX=,\0W\*#Z*96`_*L.R_P"#9O\`93M)P[^'O&%P!_!)
MXHN]I_[Y8']:WH8O"TOX4YKRT,JE"O4^.,7]YXI^S3_P6'_8V_X)>_LVVWP^
M^&^J>.?'J6<TEY=75OH[0RZI>28#S.UQY*J,(B@*#A44<D$GROXB_P#!>K]I
M/_@H;J]QX,_9E^%>I:,ET3"^IV49U._A0\;FN65+6T'/);)7LX-?HC\,/^"'
M_P"RK\);R&YT[X,^&+ZZ@(*RZPTVJG([[;EW7]*^F_"G@[2/`>APZ9H>EZ=H
MVFVXQ%:6-LEO!%_NH@"C\!6,L9A(R=2,'*7>3_1&BP]=KEE)17D?G/\`\$A/
M^"&-Y^RM\1_^%S_&O6(O%WQ>N/,EL[9;AKNVT*28$2SO._S7%VP9E,GW5#-M
MW$[Z^J?^"G7[;FC_`+`O['?BOQS?W,2ZR;9]/\.V9;$FHZG*C+`BCN%/[QSV
M2-SVK@/V]O\`@MQ\#_V$-.O+&\UZ'QKXXB4K#X8T"=+BY#\X%Q*,QVRYZ[SN
M]$;I7YO?`G]F+XY?\'#G[2UE\3_B\;OPE\&-#E9+&WMPT5LL&X%K73U?F65\
M`2W3#`Q_LK%50I5,1/ZUBW:"_JR0I5(4H^PP^LOZU9]&?\&KO[+VI?#S]F[Q
MK\4=9AE2?XBZA%::>\H(:XMK0R[YQ[//-*OU@/M7Z`?'G]DG0OVA/BW\+_%^
MKZCJ]K=_"K59M8TVWLWC6&[GD14_?;D9BH"]%*DY/-=]X"\!Z/\`"[P3I/AS
MP]IUMI&A:':1V-A96Z[8K6&-0J(H]``/>M>N#$XN56O*LM+_`);?D=5&A&%)
M4WT/'?VLOV.-,_:QO_`=[>>(_$/AG4OASKR>(](NM)%N7%TB%4+K/%(C*,YQ
MMYK/^)W["VD_M"?!#7/`OQ0\5^*?']AJUW%?6M[=K9V-YHDT0'ER6KVD$01U
M;+;F5B=S*<J2M>Y45BJ]1))/;;R-'3B[W6YX+H'[%NN2>#-1T+Q9\9OB1XWL
M+G1;W0[9-033X/)CN8#`TTI@MT:YG1&.UY2PR22I8YK1D_8=\-+^PNWP"AU3
M78O"I\.GPU]N,D3:@+<KM+;MGE[\$_P8]J]IHH]O/OY_,/9Q/,O`_P"RSHOP
M^\6>`-4L=1UD_P#"NO"4O@[3K>65&CN+60V>9)L("TH^PQ8(VCYGXY&,.T_8
M.\"Z9^W#-\?K..^LO&UYH)T&\C@=%L[Y<KB>5=NXS!$2/(8#:BY!(S7M-%)5
M9K9^0>SCV/G+1?\`@GE'\+O%GBBY^&?Q*\<?#30/&U])J>KZ!I<=C<V2W<HQ
M+<6GVFWD>TD?OL;;D*0HVBI_BK_P34\!?$3]E3PY\(-.N=<\)>&?"VJ6VL64
M^F31O>FYAE>;S9))TD$CR2NTCLP)9F)SS7T-15_6:MT[ZK^OF+V,+6L>)>)_
MV*+3XO\`PO\`%G@SXH>,O$_Q0\->+;:*VDLM7@L+5;`QN766`VEO"PE#[&#,
M6P8UQCG.)HG[`#:C;>&]*\=_%#Q[\2O"?@^\M[_2]$UL621336YS;/>RP01R
MWGE,%8"5MK,BLX<@5]$44E7J)63_`*\NWR#V4=SPO]I7]A#0_P!H#XM>&?B-
MIGB/Q+\/OB7X1@>SL/$F@20^=+:N26M;B*:.2*>'+,0CKP6)!YKG[[_@F;X;
M\2^'_BO_`,)!XM\6Z[XH^,^B1:#XDU^8VL,S6T49BC6""*%8(MJ$C[A))R2:
M^E**:Q-1))/;_A_S!TH-W:/G7Q__`,$Y=$\6>)_@QK>E>,_&7AC6/@7I$^B^
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MSA'_`,$Z;3P%\:O%7C7X9?$3QK\+I?'ES]M\2:3I4=C=Z7J-T?O72074$H@N
M&R2SQD;CU!KT'X2?LS1_"7XH:MXF3QIX]U]M5T>PTAM/UG5OM5G";56!NE3:
M,3REBTC="Q8@#.*].HHE7G)6;!4XK9!1116184444`%%%%`!1110`4444`%%
M%%`!7CW[7O[!?PJ_;H\(+I/Q(\*66M-;H5L]03,&H:?GG]S.N'49Y*DE#W4U
M[#150G*$N:#LQ2BI*TMC\8OBM_P;2_%#]G3QG-XJ_9H^,M_IEVAWQVU[>S:1
MJ``/W/M-O^[FXQPZ1K6/:?M1_P#!4/\`8[Q:^(O`U[\2-/LN/,G\/1:T95'<
MSZ<RN?J_-?MK17I+-9R5J\5/U6OWG']1BG>FW'T9^*Q_X.5_VA/AXWE^-/V:
MK*VE7[_S:CII_P"^98I"/SJ.'_@ZL^(FM9ATW]GFQFNB<*!KUS+S_NK:YK]K
M:*/KF%ZT%_X$P^KU_P#G[^"/Q3N/^"WG[<_QTC^S?#_]G.+3/M'^KNH?"VJZ
MF4'KYC%(A]2,5G7?[#?_``4A_P""AF8?B7X[O/`/AF^XGL[C58M*MWC[C[+I
MX,C?[LN,]S7[>T4_[2C#^#2BO/=B^IN7\2;?X'YP?L3?\&TGP8_9OO+36O'M
MQ<?%7Q#;D2B&]@%MH\4GK]E!8R\G_EJ[*?[@K]&--TVWT;3H+2SMX;6TM8UB
MAAA0)'"BC"JJC@````#I4]%<-?$U:TN:K*YU4J,*:M!6"BBBL#0****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
/"BBB@`HHHH`****`/__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
